GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy

This represents the third successful regulatory approval globally for GW’s plant-derived cannabis-based medicine Email Print Friendly ShareSeptember 23, 2020 03:54 ET | Source: GW Pharmaceuticals plc LONDON, Sept. 23, 2020 …

Isodiol International Inc. Default Announcement Pursuant to National Policy 12-203 Management Cease Trade Order Issued

– Isodiol International Inc. (CSE:ISOL) (CNSX:ISOL.CN) (OTC:ISOLF) (FSE:LB6B.F) (the “Company” or “Isodiol”) announces that it has not been able to file its audited annual financial statements for the fiscal year ended March 31, …

Red White & Bloom and Avicanna enter into exclusive partnership for the distribution and commercialization of Pura H&W CBD-based Topical Products in the United States

Partnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line; …

MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today …